GSK gives up Chinese patent on diabetes drug

British drug maker GlaxoSmithKline said today it was giving up a Chinese patent for a component of its popular diabetes drug Avandia following a challenge by three Chinese competitors.

GSK gives up Chinese patent on diabetes drug

British drug maker GlaxoSmithKline said today it was giving up a Chinese patent for a component of its popular diabetes drug Avandia following a challenge by three Chinese competitors.

The announcement in Beijing came six weeks after US-based Pfizer was stripped of a Chinese patent for its anti-impotence drug Viagra in a case that foreign businesses regarded as a test of China’s commitment to protecting intellectual property.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited